Evidence map›Paper›PMID 41043973›Full record

ArticleLupus science & medicine2025

Predictors of damage accrual in childhood-onset SLE: a retrospective analysis from a tertiary lupus centre in Türkiye.

Alperen Eravsar, Kaan Can Demirbas, Ece Aslan, Nergis Akay, Umit Gul, Elif Kilic Konte, Esma Aslan, Aybuke Gunalp, Fatih Haslak, Mehmet Yildiz and 5 more

Abstract read
In one paragraph

Article in Lupus science & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alperen EravsarDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Kaan Can DemirbasDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Ece AslanDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Nergis AkayDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Umit GulDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Elif Kilic KonteDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Esma AslanDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0002-7554-3320
Aybuke GunalpDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0003-0137-0460
Fatih HaslakDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Mehmet YildizDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Oya KokerDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Amra AdrovicDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.
Kenan BarutDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0001-8459-2872
Ozgur KasapcopurDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey.ORCID 0000-0002-1125-7720
Sezgin SahinDepartment of Paediatrics, Division of Paediatric Rheumatology, Istanbul University-Cerrahpasa, Faculty of Medicine, Istanbul, Turkey sezgin.sahin@iuc.edu.tr.ORCID 0000-0002-5365-3457

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSLE is a chronic autoimmune disease characterised by multisystem involvement and fluctuating clinical course, often leading to permanent organ damage. Childhood-onset SLE (cSLE) tends to be more aggressive with increased organ involvement compared with adult-onset SLE. Despite advances in treatment, there is a rising incidence of morbidity and chronic damage in cSLE patients. This study aims to evaluate the patterns of damage and identify risk factors associated with damage accrual in a cohort of cSLE patients. MATERIALS AND

methodsWe conducted a retrospective cohort study of 120 patients meeting the Systemic Lupus International Collaborating Clinics 2012 criteria for cSLE, followed by the paediatric rheumatology clinic from 2004 to March 2023. After excluding 18 patients for monogenic lupus or inadequate follow-up, 102 patients were analysed. Damage accrual was assessed using the Paediatric Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (PedSDI) and associations between clinical, laboratory and demographic variables with damage accrual were evaluated using univariate and multivariate analyses.

resultsThe mean age at diagnosis was 12.9 years, with a mean disease duration of 6.3 years. At the end of the study, 33.3% of patients had accrued damage (PedSDI≥1). The most frequently involved domains were growth failure (24%), renal (11.8%), neuropsychiatric (8.8%) and mucocutaneous (5.9%). Multivariate analysis revealed that higher median SLE Disease Activity Index-2000 scores, haemolytic anaemia and renal involvement were independent risk factors for damage accrual.

conclusionsOur study confirms that higher median disease activity over time, haemolytic anaemia and renal disease are significant predictors of long-term damage in cSLE. Additionally, growth failure was the most frequently involved domain in PedSDI, followed by renal and neuropsychiatric domains. These findings underscore the importance of early and effective disease management and regular monitoring for these risk factors.

Indexed as

Lupus Erythematosus, SystemicAdolescentAge of OnsetChildChild, PreschoolDisease ProgressionFemaleHumansMaleRetrospective StudiesRisk FactorsSeverity of Illness IndexTertiary Care CentersAutoimmune DiseasesDisease ActivityRisk FactorsSystemic Lupus Erythematosus

Identifiers

PMID41043973
PMCPMC12551505

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.